From Biomarkers to Breakthroughs

The Latest on Tau and Neurodegeneration

The Evolving Role of Tau in Neurodegeneration: A comprehensive look at Biomarkers and Clinical Applications

Key highlights include

– The role of Tau in neurodegeneration and disease progression – Emerging blood-based biomarkers for early detection – Advances in precision diagnostics with Simoa® technology

Access the whitepaper

Continued Learning

View these additional resources curated by Quanterix experts

p-Tau 217 for AD Detection

A JAMA Neurology study highlighted the Simoa® ALZpath p-Tau 217 assay’s accuracy in detecting Alzheimer’s disease pathology, differentiating it from other conditions, and tracking disease progression over time.

BD-Tau: What You Should Know

Learn how BD-Tau improves the detection and monitoring of Alzheimer’s and other neurological diseases. Read about its unique brain specificity, how it compares to other biomarkers, and its potential impact on research and diagnostics.

Subscribe to Our Newsletter

We’ve launched our brand-new newsletter. Twice a month we share news from the industry, publications, and more. Subscribe today!

Explore ultra-sensitive biomarker detection solutions

Talk to an expert